Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Righttothetopon Feb 04, 2021 1:41pm
70 Views
Post# 32471877

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated payments and shares issued....

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated payments and shares issued....Valens took it on the chin because people perceived that NR in a negative way (obvious but not exactly warranted) and they are now getting the LABS manipulation treatment as a result.

The way the offering was structured, it gave the shorts free reign....just like LABS.  They aren't insulated anymore so games are driving that SP down...despite doing many if not all things right.  IMO

Lemoyne wrote:
allibabba wrote: At the end of the day guys, if you want to see what happens to the SP when this is announced just go look at valens when they announced and where they went after the news dropped.  Not super encouraging.


Totally different IMO, on top of the 150M prospectus they also announced a bought deal at 2.05$ while their stock price was peaking at 2.70. Plus, they acquired a local canadian edible manufacturer.... What's the point of expanding locally while USA is booming?

I don't think the prospectus itself caused the dramatic drop...



<< Previous
Bullboard Posts
Next >>